In contrast, the p53 expression was dramatically less in benign (6%) than borderline (75%) and malignant tumors (81%), the differences being highly significant 73 .
← all excerpts
The Putative Role of <i>TP53</i> Alterations and p53 Expression in Borderline Ovarian Tumors - Correlation with Clinicopathological Features and Prognosis: A Mini-Review.
1
—
—